Key statistics
On Tuesday, Cytodyn Inc (CYDY:QBB) closed at 0.1543, 39.03% above the 52 week low of 0.111 set on Aug 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.1506 |
---|---|
High | 0.159 |
Low | 0.1452 |
Bid | -- |
Offer | -- |
Previous close | 0.1499 |
Average volume | 2.15m |
---|---|
Shares outstanding | 1.21bn |
Free float | 1.21bn |
P/E (TTM) | -- |
Market cap | 187.48m USD |
EPS (TTM) | -0.0527 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 20:59 BST.
More ▼
Announcements
- CytoDyn Appoints Dr. Max Lataillade as Senior Vice President and Head of Clinical Development
- CytoDyn Announces Abstract that Highlights Leronlimab’s Potential in Mediating ART-Free Viral Control in Infant Rhesus Macaques
- CytoDyn Engages Syneos Health as CRO For Its Phase II Oncology Trial
- CytoDyn Announces Preliminary Findings in Study with SMC Laboratories
- September 2024 Letter to Shareholders
- CytoDyn Engages Leading CRO For Phase II Inflammation Trial
- CytoDyn Announces Completion of FDA Meeting on Phase II Study of Leronlimab in Patients with Relapsed/Refractory Microsatellite Stable Colorectal Cancer
- CytoDyn Announces Settlement with Amarex Clinical Research LLC
- CytoDyn Announces Start of Preclinical MASH Study, Results Expected in Fall 2024
- CytoDyn to Host Webcast to Provide Company Update
More ▼